» Articles » PMID: 35769960

Mutation-Related Spinocerebellar Ataxia Type 18: A New Report and Literature Review

Overview
Journal J Pediatr Genet
Publisher Thieme
Specialty Pediatrics
Date 2022 Jun 30
PMID 35769960
Authors
Affiliations
Soon will be listed here.
Abstract

Spinocerebellar ataxias (SCAs) are heterogeneous disorders with multiple genetic etiology. Mutations in the gene are associated with spinocerebellar ataxia type 18 (SCA-18). We report the first Indian case of SCA-18. The proband is a 7-year-old boy with motor delay, cerebellar signs, and cerebellar atrophy. Whole exome and direct sequencing identified compound heterozygous mutations of the coding and noncoding regions of the gene. A literature review of the published cases with pathogenic variants was performed. Beside our patients, 32 cases were identified. The majority of reported cases were males, of consanguineous kindreds, with autosomal recessive inheritance. However, a proportion of cases (39%) had autosomal dominant/semidominant inheritance with heterozygous variants. In addition to childhood-onset cerebellar ataxia, other reported features were: early-onset dementia, complicated spastic paraparesis, retinal dystrophy, hearing loss, lower motor neuron signs, and severe global developmental delay in some homozygous cases. Cerebellar atrophy was the commonest neuroimaging finding, with few cases demonstrating brain stem, supratentorial, and white matter abnormalities. Although SCA-18 should be suspected in patients with early-onset cerebellar ataxia, eye movement abnormalities, and motor delay, clinicians should be aware of late-onset, variable presentations with pyramidal signs, dementia, and hearing loss. In suspected cases, if mutations were not detected by whole-exome sequencing, direct sequencing of noncoding regions and chromosomal microarray should be considered.

Citing Articles

Loss of activation by GABA in vertebrate delta ionotropic glutamate receptors.

Rosano G, Barzasi A, Lynagh T Proc Natl Acad Sci U S A. 2024; 121(6):e2313853121.

PMID: 38285949 PMC: 10861852. DOI: 10.1073/pnas.2313853121.


In Cerebellar Atrophy of 12-Month-Old ATM-Null Mice, Transcriptome Upregulations Concern Most Neurotransmission and Neuropeptide Pathways, While Downregulations Affect Prominently Itpr1, Usp2 and Non-Coding RNA.

Reichlmeir M, Canet-Pons J, Koepf G, Nurieva W, Duecker R, Doering C Cells. 2023; 12(19).

PMID: 37830614 PMC: 10572167. DOI: 10.3390/cells12192399.

References
1.
Panda P, Sharawat I . COL6A3 mutation associated early-onset isolated dystonia (DYT)-27: Report of a new case and review of published literature. Brain Dev. 2020; 42(4):329-335. DOI: 10.1016/j.braindev.2020.01.004. View

2.
Souza P, Pinto W, Batistella G, Bortholin T, Oliveira A . Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks. Cerebellum. 2016; 16(2):525-551. DOI: 10.1007/s12311-016-0803-z. View

3.
Coutelier M, Hammer M, Stevanin G, Monin M, Davoine C, Mochel F . Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes. JAMA Neurol. 2018; 75(5):591-599. PMC: 5885259. DOI: 10.1001/jamaneurol.2017.5121. View

4.
Fogel B, Lee H, Deignan J, Strom S, Kantarci S, Wang X . Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol. 2014; 71(10):1237-46. PMC: 4324730. DOI: 10.1001/jamaneurol.2014.1944. View

5.
Buijsen R, Toonen L, Gardiner S, van Roon-Mom W . Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias. Neurotherapeutics. 2019; 16(2):263-286. PMC: 6554265. DOI: 10.1007/s13311-018-00696-y. View